Clinical Trial Update: Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 trial comparing early versus late Bacillus Calmette-Guérin vaccination in HIV-exposed infants in Uganda, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Lower Respiratory Tract Infection
• Sepsis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Makerere University | Conditions: Severe Illness, Septicaemia | Phase 3 | Status: COMPLETED